Results 261 to 270 of about 2,119,412 (309)
Anti-Obesity Mechanisms of Plant and Fungal Polysaccharides: The Impact of Structural Diversity. [PDF]
Fang G +5 more
europepmc +1 more source
This study analyzes 148 patients (66 women and 82 men) with chronic myeloid leukemia treated with tyrosine kinase inhibitors, focusing on cardiovascular adverse events. The risk assessment, performed using the HFA/ICOS score, reveals sex‐specific differences: venous thrombosis is more common in women, while arterial thrombosis predominates in men.
Cristina Madaudo +10 more
wiley +1 more source
Subjective and Objective Assessments of Olfactory Function in Patients Taking Anti-obesity Medications. [PDF]
Lee HJ, Kwak IY, Min HJ.
europepmc +1 more source
Bridging bench to bedside: a dual-use framework for chromene-based anti-obesity and antiviral therapeutics. [PDF]
Chávez-Jiménez SK +5 more
europepmc +1 more source
Adipose Tissue, at the Core of the Action of Incretin and Glucagon-Based Anti-Obesity Drugs. [PDF]
Villarroya F, Peyrou M, Giralt M.
europepmc +1 more source
A glimpse into the pipeline of anti-obesity medication development: combining multiple receptor pathways. [PDF]
Park C, Kim Y, Raygani S, Grunvald E.
europepmc +1 more source
Subjective Olfactory Impairment in a Patient Undergoing Anti-Obesity Pharmacotherapy: A Case of Symptom-Test Discrepancy. [PDF]
Lee HJ, Min HJ.
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
A study of an anti-obesity, anti-obesity campaign
2021Since the declaration of the “war on obesity,” there have been many attempts to curb the so-called “obesity epidemic.” Indeed, anti-obesity campaigns communicating a “fat-as-fatal” message have become a regular and accepted public health strategy in most economically developed countries.
Lee, Jessica, Williams, Benjamin
openaire +3 more sources

